PR.com is a leader in paid and free press release distribution.
To reach journalists, increase online visibility, and attract new customers,
submit via our global online news and press release distribution service to
top search engines, thousands of websites, social media, blogger networks,
as well as via print, broadcast, radio, mobile channels, and more.
Leona W. Ayers, M.D. of Dublin, Ohio has been acknowledged as a Most Influential Business Professional for 2018 by Strathmore’s Who’s Who Worldwide for her outstanding achievements and high level of success for over 40 years in the fields of education and medical research.
About Leona W. - June 02, 2018 - Strathmore Worldwide
Research shows the HPV vaccine prevents cancer, and preteens can be protected by strong provider recommendation. Enrollment is now open for pediatricians in Illinois and Wisconsin for an accredited quality improvement project to increase vaccination rates, and participants can register on an individual basis or by practice. - May 24, 2018 - Wisconsin Chapter, American Academy of Pediatrics
The Colorado Blood Cancer Institute (CBCI), in partnership with Sarah Cannon Cancer Institute (Sarah Cannon) at HealthONE’s Presbyterian/St. Luke’s Medical Center (P/SL), successfully completed its 4,000th blood and marrow, or stem cell, transplant since the inception of the program in 1991. - May 11, 2018 - Presbyterian/St. Luke's Medical Center
What happens when groundbreaking technology meets industry leadership?
This spring, healthcare solutions company Vital Vio and lighting manufacturer Visa Lighting will introduce LED disinfection technology to a wide range of applications.
Collaboration has always been the creative approach that makes... - April 10, 2018 - Visa Lighting
Leona W. Ayers, M.D. of Dublin, Ohio has been honored as a Woman of Distinction for the second quarter of 2018 by P.O.W.E.R. (Professional Organization of Women of Excellence Recognized) for her outstanding achievements and high level of success in the field of education. Each quarter P.O.W.E.R. chooses... - April 06, 2018 - P.O.W.E.R. Professional Organization of Women of Excellence Recognized
Jeff Slivka, president of New Day Underwriting Managers LLC, recently explored the ripple effects of OSHA’s new silica standard on the legal, insurance, and construction environments at the 2018 Conference on Surety Bonding & Construction Risk Management. Hosted by the Associated General Contractors... - February 13, 2018 - New Day Underwriting Managers
The CDC has reported a sharp increase in influenza activity in the U.S. in recent weeks, with South Florida hit particularly hard due to an influx of winter travelers. To curb complications from the virus, MD Now is offering prescriptions for antiviral medications as appropriate, at all 33 South Florida... - February 04, 2018 - MD Now Urgent Care
Building on the success of SMi's 10th Annual Flagship Conference Pre-Filled Syringes, SMi are thrilled to present the launch of their Injectable Drug Delivery conference being held at Holiday Inn, Kensington Forum, London, on the 16th – 17th May 2018.
Their global panel of speakers will strengthen... - January 25, 2018 - SMi Group
Christopher Houchens of BARDA talks about Incentivizing Antibacterial Research and Development SMi’s Superbugs & Superdrugs Conference 2018 - January 03, 2018 - SMi Group
MHRA to provide news updates on regulatory considerations at 20th annual “Superbugs” summit. - December 15, 2017 - SMi Group
GeneFluidics, a molecular diagnostics company specializing in the development of diagnostics solutions for infectious diseases, today announced CE marking for UtiMax™ under the Directive 98/79/EC on in vitro diagnostic medical devices. UtiMax™has successfully completed a multicenter validation study and clinical testing. It does not require clinical isolates from urine cultures, enabling a rapid ID reporting in as short as 30 minutes and AST in 120 minutes for a positive ID result. - December 10, 2017 - GeneFluidics Inc.
SMi Reports: Expert insight into tackling the scientific, regulatory and economic challenges to combat antimicrobial resistance. - November 24, 2017 - SMi Group
A new consumer-interest column is being offered free to the media by the founder of a multi-media marketing company to mark the 61st anniversary of ACT., Inc, Philadelphia.
The article is headlined “Handicapped? Using a walker has its benefits. Like Walking!”
The author is Joe Ball, President,... - October 28, 2017 - ACT, Inc.
Working KnowledgeCSP (WK), a recognized US and international provider of knowledge management solutions, announced a competitive contract award for Knowledge Management (KM) Consulting Services Contract from The Global Fund to Fight AIDS, Tuberculosis and Malaria, headquartered in Geneva, Switzerland.
Under... - October 27, 2017 - Working Knowledge CSP
M.M. Drymon releases new e-Book "The Persistent Spiral." - October 27, 2017 - M. M. Drymon
SMi Group will open doors in 3 weeks to host the next annual USA Superbugs summit when it returns to Iselin, New Jersey on Nov 13th – 14th. www.superbugs-usa.com/prc
Following over two decades of expertise in Europe, the USA show will gather senior industry experts to delve deeper into core issues... - October 25, 2017 - SMi Group
Save big on The Solution HEPA-filtered Mobile Containment Units during Infection Prevention Week from October 15-21. - October 11, 2017 - Prevent Life Safety
SMI REPORTS: Industry meeting on antimicrobial resistance returns to Iselin, New Jersey this fall. - October 09, 2017 - SMi Group
SMi Reports: Superbugs & Superdrugs USA returns to Iselin, New Jersey on 13th and 14th November 2017. - October 02, 2017 - SMi Group
Mapp Biopharmaceutical, Inc., announced today that it has been awarded a Project BioShield contract (HHSO100201700017C) of approximately $46 million by The Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the... - September 30, 2017 - Mapp Biopharmaceutical, Inc.
UNT Health Science Centre to lead interactive workshop at the next annual USA meeting on Superbugs and Superdrugs. - September 21, 2017 - SMi Group
"Where a Booger Goes," Andrews’ first book (set for release by Black Swan Publishing, LLC on 10/21/2017), highlights inappropriate booger-disposal habits by several cartoon children before reaching the conclusion of where a booger truly belongs. The illustrated boogers in the book are full of character and personality, and manage to be disgusting and adorable at the same time. - September 13, 2017 - Black Swan Publishing, LLC
New Interview Out with Motif Biosciences in the run up to their keynote address at Superbugs & Superdrugs USA this Fall. - September 12, 2017 - SMi Group
Tim Opperman, Senior Research Scientist from Microbiotix, unveils new updates at SMi's next Annual Superbugs and Superdrugs USA Summit. - July 13, 2017 - SMi Group
Africa Water Wells, founded by Sandy & Bud Mulcahy, has expanded their mission beyond clean water to include free AA and medical care, women's empowerment programs, and donated used laptops to primary schools in and around Sotik. They are now fundraising for additional water wells including two for Schools for the Deaf without access to clean water in Sotik, Kenya. - July 12, 2017 - Lee Mulcahy
Coppe Laboratories conducted patient testing research in Wisconsin among 95 Lyme suspected patients. Within the 95 patient cohort, 41 were tested positive for Lyme disease. Of the 41 tested positive it was demonstrated in the research that approx. 17% of patients were also positive for Powassan Virus. - July 11, 2017 - Coppe Laboratories
Infectious disease specialist John Rex will open SMi’s next annual show on antimicrobial resistance when it returns to North America this fall. BARDA, Pfizer, Visterra and ContraFect also included on the notable speaker line-up for 2017. - June 22, 2017 - SMi Group
The SAGE Health Storylines self care app was designed in partnership with SAGE & Self Care Catalysts to support the health and well being of older adults within the LGBT community. Please help spread the word and support the health and well being of the diverse senior community. - June 09, 2017 - Self Care Catalysts
G&L Scientific Inc, a company founded by Peter Griffin and Stephen Loughrey, who together built Pharmalink Consulting into the leading, independent Regulatory Affairs specialist, today announced their intention to once more provide Regulatory Affairs services to life-science clients.
G&L Scientific,... - June 02, 2017 - G&L Scientific Inc
Hepatitis E Diagnostic Tests Market by Test Type (ELISA HEV IgM Test Kits, ELISA HEV IgG Test Kits, RT-PCR Test Kits, Others), End Users (Diagnostic Laboratories, Hospitals, Point-of-Care) and Forecast 2017-2021. - April 30, 2017 - iHealthcareAnalyst, Inc.
Xavier A. Baruti inspires his 9 employees to meet people where they live...at home. Baruti heads up the Atlanta, Georgia based Get Well Mobile STD Screening LLC to slow the increasing rate of STDs in the city. Baruti reports wanting to make STD testing quick, affordable and convenient for the 5.6 million... - April 24, 2017 - Get Well Mobile STD Screening
EMLab P&K’s microbiology laboratory in Chicago, Illinois receives accreditation from AIHA-LAP, LLC for Legionella testing. EMLab P&K continues expanding its Legionella analysis capacity nationwide. - April 07, 2017 - EMLab P&K IAQ Laboratory
Lateral Flow Disease Testing Market by Application (Hepatitis, HIV, Influenza, Malaria, Pregnancy, Syphilis), and End Users (Hospitals, Home Testing, Community Testing, Laboratory Testing) 2016-2020 - March 30, 2017 - iHealthcareAnalyst, Inc.
Hospital-Acquired Infection Therapeutics Market by Drug Type (Antibacterial, Antifungal and Antiviral Drugs), Clinical Pipeline Analysis of Phase 1, 2 and 3 Drugs (Amikacin Inhale, CAZ AVI Ceftolozane, Dalvance, Delafloxacin, Eravacycline, MK-3415A, Oritavancin, Plazomicin, Surotomycin, Tedizolid), and Indications (Blood Stream Infections, Gastrointestinal Disorders, HAP, SSIs, UTIs) 2016-2020 - March 08, 2017 - iHealthcareAnalyst, Inc.
Hospital Acquired Disease Testing Market by Test Type (Blood Stream Associated Infection, MRSA Infection, Hospital-Acquired Pneumonia, Surgical Associated Infection, UTI, Gastroenteritis, Puerperal Fever) 2016-2020. - March 04, 2017 - iHealthcareAnalyst, Inc.
Enteric Disease Testing Market by Causal Organism for Enteric Disease Type (Bacterial Agents – C. difficile, Campylobacteriosis, Cholera, E. coli, H. pylori, Salmonellosis, Shigellosis; Viral Agents – Norovirus, Rotavirus; and Parasitic Agents – Amebiasis, Cryptosporidiosis, Giardiasis) 2016-2020 - February 18, 2017 - iHealthcareAnalyst, Inc.
The agenda has been released and registration is now open for SMi’s Pharmaceutical Microbiology USA show. The seventh in its series, this event will take place in San Diego, on the 8th and 9th June 2017. - February 16, 2017 - SMi Group
Report presents a brief overview of the global market along with psoriasis treatment .It also provides information and data analysis of the global market with respect to the segments based on products, distribution channel, therapy type and geography. - February 03, 2017 - Market Research Hub
Report titled "Rheumatoid Arthritis" has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. - February 01, 2017 - Market Research Hub
G&L Scientific Inc, the leading provider of clinical and scientific consulting and resource to the healthcare industry (http://www.gandlscientific.com), has announced the opening of new offices in Cambridge, Massachusetts, strengthening and improving access to its expanding team of clinical and scientific consultants and contractors. This is the latest step in G&L’s expansion of its global clinical consulting services throughout the United States. - January 19, 2017 - G&L Scientific Inc
SMi Reports: Superbugs & Superdrugs 2017 returns to Central London for its 19th Annual Show this March. - January 12, 2017 - SMi Group
FDA Division of Anti-Infective Products Director, Sumathi Nambair, due to Present at Superbugs & Superdrugs 2017. - December 02, 2016 - SMi Group
Report provides broad information on the therapeutics under development for tuberculosis globally. This covers the descriptive pharmacological action of the therapeutics with its complete research & development history. - December 02, 2016 - Market Research Hub
The global hospital-acquired pneumonia drugs (Phase III) market is estimated to reach USD 3.8 Billion in 2020, published by iHealthcareAnalyst, Inc.
Visit the Hospital-Acquired Pneumonia Drugs (Phase III) Market – Amikacin Inhale, Ceftazidime (Avibactum), Ceftolozane (Tazobactam), Plazomicin,... - December 01, 2016 - iHealthcareAnalyst, Inc.
Report offers a brief overview about German measles disease and its therapeutic development. It is an infectious disease caused by a virus called “Rubella.” This directly infects the skin and lymph nodes. The main symptom is a pink spotty rash that starts from the face and spreads to the arms & chest. - November 26, 2016 - Market Research Hub
Announcing an agreement to purchase patent and IP technology from UCSD for a novel way to track medical instruments using Nano Quantum Dots - November 25, 2016 - Global Cancer Technology, Inc
As complex surgical instruments replace simpler surgical instruments for minimally invasive surgery and faster recovery time for patients, advanced education is required to insure the sterile processing of these complex surgical instruments. Sadly, 290,000 patients suffer surgical site infections mostly from the use of contaminated surgical instruments every year. From a layman’s perspective, 800 Americans will suffer surgical site infections today - some will not make it. - October 14, 2016 - The Consortium of Sterile Sciences
Besides the high number of dengue cases in Malaysia, Zika infections have also started to emerge locally. Learn what could be the main contributory factors and what can be done to curb this. - October 10, 2016 - Rentokil Initial
National nonprofit’s new website offers improved user experience, simplified navigation as a trusted global authority for information about hepatitis B. - September 24, 2016 - Hepatitis B Foundation
Infection control is policies and procedures followed to minimize the threat of acquiring, spreading infections, especially in hospitals and other healthcare facilities. Healthcare-acquired infections (HCAI) continue to be a major safety concern for both health care providers and the patients, thus prevention and control of healthcare-associated infections remains a priority. - September 24, 2016 - IQ4I Research & Consultancy Pvt. Ltd.